CASI Pharmaceuticals
CASI
#10379
Rank
A$6.09 M
Marketcap
A$0.30
Share price
0.00%
Change (1 day)
-91.66%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$54.39 Million a decrease over its 2023 earnings that were of -A$37.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million35.5%
2024 -A$54.39 Million44.35%
2023 -A$37.68 Million-29.55%
2022 -A$53.48 Million4.43%
2021 -A$51.21 Million-24.56%
2020 -A$67.88 Million4.74%
2019 -A$64.81 Million65.13%
2018 -A$39.25 Million155.07%
2017 -A$15.39 Million13.93%
2016 -A$13.51 Million31.18%
2015 -A$10.3 Million-72.5%
2014 -A$37.44 Million356.62%
2013 -A$8.2 Million-60.55%
2012 -A$20.79 Million218.41%
2011 -A$6.53 Million0.74%
2010 -A$6.48 Million-32.54%
2009 -A$9.61 Million-66.98%
2008 -A$29.09 Million-14.22%
2007 -A$33.91 Million7.04%
2006 -A$31.68 Million27.95%
2005 -A$24.76 Million4.51%
2004 -A$23.69 Million-15.84%
2003 -A$28.15 Million-55.29%
2002 -A$62.96 Million-34.05%
2001 -A$95.46 Million31.73%
2000 -A$72.47 Million31.56%
1999 -A$55.08 Million145.56%
1998 -A$22.44 Million76.4%
1997 -A$12.72 Million36.92%
1996 -A$9.29 Million